Association study of TAP and HLA-I gene combination with chronic hepatitis C virus infection in a Han population in China
- PMID: 35485366
- DOI: 10.1111/iji.12574
Association study of TAP and HLA-I gene combination with chronic hepatitis C virus infection in a Han population in China
Abstract
Host immune system genes play key roles in the progression of chronic hepatitis C virus (HCV) infection. Transporters associated with antigen processing (TAP) play an important role in the loading of viral peptides onto MHC class I molecules. This study aimed to investigate the association between TAP gene polymorphisms and chronic HCV in a Chinese Han population. A total of 232 chronic hepatitis C (CHC) patients and 362 healthy individuals were recruited from the Han population in Yunnan province in southwest China, and a TaqMan SNP genotyping assay was used to detect six single nucleotide polymorphisms (SNPs) of TAP1 and three SNPs of TAP2 genes. The association of the TAP gene with CHC was analysed at the allele, genotype, and haplotype levels. There were no significant differences in the allele and genotype frequencies of these SNPs in the TAP gene between CHC patients and controls after Bonferroni correction. A novel TAP1 allele (TAP1*unknown_1: rs41555220-rs41549617-rs1057141-rs1135216-rs1057149-rs41551515: G-G-A-G-G-G) was only present in the CHC group, and this allele significantly increased susceptibility to CHC (p = .005, odds ratio [OR] = 11.105. 95% confidence interval [CI]: 1.362-90.558). Homozygous TAP1*03:01/TAP1*03:01 was observed only in the CHC group that exhibited an obvious risk for CHC (p = .002, OR = 9.637, 95% CI: 1.153-80.574). And the haplotype TAP1*unknown_1-TAP2*01:01 was only present in the CHC group and indicated a significant risk for CHC (p = .002, OR = 9.498, 95% CI: 1.140-79.149). We observed significant interactions among HLA-A, -B,C, TAP1, and TAP2 alleles, and combination analysis revealed that the combination of TAP1*01:01-TAP2*01:01-HLA-B*35:01 was only present in the control group (2.2%) and resulted in significantly increased resistance to CHC (p = .002, OR = 0.096, 95% CI: 0.012-0.759). Whereas, the combination of TAP1*01:01-TAP2*01:01-HLA-C*07:02 and TAP1*03:01-TAP2*01:01-HLA-C*01:02 increased the susceptibility to CHC significantly (p = .001, OR = 2.016, 95% CI: 1.309-3.106 and p = .002, OR = 8.070, 95% CI: 1.018-63.997, respectively). Our results indicated that TAP and HLA-I may exert a combined effect on CHC susceptibility in the Chinese Han population.
Keywords: HLA class I; Han Chinese; TAP1 and TAP2; chronic hepatitis C infection; polymorphisms.
© 2022 John Wiley & Sons Ltd.
Similar articles
-
Polymorphisms in transporter associated with antigen presenting are associated with cervical intraepithelial neoplasia and cervical cancer in a Chinese Han population.HLA. 2021 Jul;98(1):23-36. doi: 10.1111/tan.14333. Epub 2021 Jun 5. HLA. 2021. PMID: 34050605
-
The association of TAP polymorphisms with non-small-cell lung cancer in the Han Chinese population.Hum Immunol. 2021 Dec;82(12):917-922. doi: 10.1016/j.humimm.2021.07.014. Epub 2021 Aug 7. Hum Immunol. 2021. PMID: 34373132 Clinical Trial.
-
Transporter Associated with Antigen Processing 1 Gene Polymorphisms Increase the Susceptibility to Tuberculosis.Pharmgenomics Pers Med. 2023 Apr 13;16:325-336. doi: 10.2147/PGPM.S404339. eCollection 2023. Pharmgenomics Pers Med. 2023. PMID: 37077653 Free PMC article.
-
Genetic association between TAP1 and TAP2 polymorphisms and ankylosing spondylitis: a systematic review and meta-analysis.Inflamm Res. 2017 Aug;66(8):653-661. doi: 10.1007/s00011-017-1047-1. Epub 2017 Apr 12. Inflamm Res. 2017. PMID: 28405734
-
Drugs for Chronic Hepatitis C Infection: Cost-Effectiveness Analysis [Internet].Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Jan. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Jan. PMID: 27077173 Free Books & Documents. Review.
References
REFERENCES
-
- Beismann-Driemeyer, S., & Tampe, R. (2004). Function of the antigen transport complex TAP in cellular immunity. Angewandte Chemie (International ed in English), 43(31), 4014-4031. https://doi.org/10.1002/anie.200300642
-
- Cazarez-Navarro, G., Palomares-Marín, J., Rodríguez-Preciado, S. Y., Pereira-Suárez, A. L., Martínez-López, E., Bacilio-Medrano, E. A., Huerta-Olvera, S., & Hernández, C. II (2021). Association of TAP1 1177A>G and 2090A>G gene polymorphisms with latent tuberculosis infections in sheltered populations, in the metropolitan area of Guadalajara, Mexico: A pilot study. Revista Do Instituto De Medicina Tropical De Sao Paulo, 63, e55. https://doi.org/10.1590/s1678-9946202163055
-
- Chinese Society of Hepatology, C. M. A. C. S. o. I. D., Chinese Medical Association. (2019). Guidelines for the prevention and treatment of chronic hepatitis C (2019 version). Journal of Clinical Hepatology, 35(12), 2670-2686.
-
- Cui, Q., Zhang, Y., Su, J., Shi, C., Lei, N., Ding, K., Li, J., Yu, R., Wang, L., & Wang, N. (2010). The association between the genetic polymorphisms of LMP2/LMP7 and the outcomes of HCV infection among drug users. The Journal of Biomedical Research, 24(5), 374-380. https://doi.org/10.1016/S1674-8301(10)60050-4
-
- Feng, M. L., Yin, B., Shen, T., Ma, Q., Liu, L., Zheng, J., Zhao, Y., Qian, K., & Liu, D. (2009). TAP1 and TAP2 polymorphisms associated with ankylosing spondylitis in genetically homogenous Chinese Han population. Human Immunology, 70(4), 257-261. https://doi.org/10.1016/j.humimm.2009.01.028
MeSH terms
Substances
Grants and funding
- 81160197/National Natural Science Foundation of China
- 320.6750.13395/Wujieping Medical Grant
- L- 201615/Special Funds for high-level health talents of Yunnan Province
- D-201669/Special Funds for high-level health talents of Yunnan Province
- H-2018014/Special Funds for high-level health talents of Yunnan Province
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous